cysteine has been researched along with bardoxolone methyl in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Ahmad, R; Kharbanda, S; Kufe, D; Meyer, C; Raina, D | 1 |
| Basagni, F; Lanni, C; Minarini, A; Rosini, M | 1 |
| Gatbonton-Schwager, T; Joshi, T; Kensler, TW; Srinivasan, H; Suzuki, T; Wakabayashi, N; Yagishita, Y; Yamamoto, M | 1 |
1 review(s) available for cysteine and bardoxolone methyl
| Article | Year |
|---|---|
Lights and shadows of electrophile signaling: focus on the Nrf2-Keap1 pathway.
Topics: Animals; Antioxidants; Cysteine; Dimethyl Fumarate; Drug Design; Humans; Kelch-Like ECH-Associated Protein 1; Molecular Structure; NF-E2-Related Factor 2; Oleanolic Acid; Oxidation-Reduction; Oxidative Stress; Signal Transduction; Structure-Activity Relationship | 2019 |
2 other study(ies) available for cysteine and bardoxolone methyl
| Article | Year |
|---|---|
Triterpenoid CDDO-Me blocks the NF-kappaB pathway by direct inhibition of IKKbeta on Cys-179.
Topics: Cell Line; Cysteine; Enzyme Inhibitors; Humans; I-kappa B Kinase; Mutation; NF-kappa B; Oleanolic Acid; Oxidation-Reduction; Oxygen; Phosphorylation; Recombinant Proteins; Subcellular Fractions; Tumor Necrosis Factor-alpha; U937 Cells | 2006 |
A Point Mutation at C151 of
Topics: Animals; Cysteine; Cytoprotection; Hepatitis; Kelch-Like ECH-Associated Protein 1; Mice; Mice, Knockout; NF-E2-Related Factor 2; Oleanolic Acid; Point Mutation; Signal Transduction | 2023 |